Difficulty: Medium
Average Score: 81%
Practice
This drug is a Class III antiarrhythmic drug:
Correct answer
B
Rationale
The correct answer is B) Sotalol. Sotalol is classified as a Class III antiarrhythmic drug because it primarily affects the potassium channels in cardiac cells, leading to prolongation of the action potential duration and refractory period. This class of drugs is known for their ability to treat various types of arrhythmias by stabilizing the heart's rhythm.
Now, let's explore why the other options are incorrect:
A) Flecainide is a Class IC antiarrhythmic drug that works by blocking sodium channels.
C) Lidocaine is a Class IB antiarrhythmic drug that also acts by blocking sodium channels.
D) Verapamil is a calcium channel blocker and is classified as a Class IV antiarrhythmic drug, not Class III.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for nursing pharmacology practice. Knowing the specific mechanisms of action for each class helps nurses make informed decisions when administering these medications to patients with cardiac arrhythmias. This knowledge is essential for ensuring safe and effective patient care, as the wrong antiarrhythmic drug could potentially worsen a patient's condition.
Now, let's explore why the other options are incorrect:
A) Flecainide is a Class IC antiarrhythmic drug that works by blocking sodium channels.
C) Lidocaine is a Class IB antiarrhythmic drug that also acts by blocking sodium channels.
D) Verapamil is a calcium channel blocker and is classified as a Class IV antiarrhythmic drug, not Class III.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for nursing pharmacology practice. Knowing the specific mechanisms of action for each class helps nurses make informed decisions when administering these medications to patients with cardiac arrhythmias. This knowledge is essential for ensuring safe and effective patient care, as the wrong antiarrhythmic drug could potentially worsen a patient's condition.